SPONSOR
Novelwise Pharmaceutical Corporation
Total Trials
2
Recruiting
2
Phases
Phase 1, Phase 2
Conditions studied: Metastatic Uveal MelanomaUveal Melanoma, MetastaticUveal Melanoma, RecurrentEye Cancer, Intraocular MelanomaEye CancerMalignant NeoplasmMalignant Neoplasm of Brain
NCT07136181 Phase 1, Phase 2
Recruiting
Evaluation of the Safety, Efficacy, and Pharmacokinetics of NBM-BMX in Patients With Metastatic Uveal Melanoma
Metastatic Uveal Melanoma
NCT06012695 Phase 1, Phase 2
Recruiting
NBM-BMX Administered Orally to Patients with Solid Tumors or Newly Diagnosed Glioblastoma
Malignant Neoplasm